Clinical Trial Update: RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes [Phase 3]

View source ↗

Summary

Phase 3 RECORD trial evaluating rosiglitazone for cardiac outcomes and glycemic control in type 2 diabetes; the study status is completed with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Rosiglitazone (rosiglitazone)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2009-11-13